Rituximab Therapy for Mucous Membrane Pemphigoid: A Retrospective Monocentric Study With Long-Term Follow-Up in 109 Patients

Mucous membrane pemphigoid (MMP) is a heterogeneous group of rare, chronic, subepithelial autoimmune blistering diseases (AIBDs) with predominant involvement of mucous membranes that can be sight-threatening and life-threatening. Rituximab (RTX) has demonstrated its efficacy in severe MMP refractory...

Descripción completa

Detalles Bibliográficos
Autores principales: Bohelay, Gérôme, Alexandre, Marina, Le Roux-Villet, Christelle, Sitbon, Ishaï, Doan, Serge, Soued, Isaac, Shourick, Jason, Rousset, Laurie, Mellottee, Benoît, Heller, Michel, Lièvre, Nicole, Zumelzu, Coralie, Morin, Florence, Grootenboer-Mignot, Sabine, Gabison, Eric, Caux, Frédéric, Prost-Squarcioni, Catherine, Musette, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281543/
https://www.ncbi.nlm.nih.gov/pubmed/35844526
http://dx.doi.org/10.3389/fimmu.2022.915205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281543/
https://www.ncbi.nlm.nih.gov/pubmed/35844526
http://dx.doi.org/10.3389/fimmu.2022.915205

Ejemplares similares